Ostrow S - Search Results

1

Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcoma.

Gerad H, van Echo DA, Whitacre M, Ashman M, Helrich M, Foy J, Ostrow S, Wiernik PH, Aisner J. Gerad H, et al. Among authors: ostrow s. Cancer. 1984 Jun 15;53(12):2585-91. doi: 10.1002/1097-0142(19840615)53:12<2585::aid-cncr2820531203>3.0.co;2-2. Cancer. 1984. PMID: 6722720

2

Physiologic response and toxicity in patients undergoing whole-body hyperthermia for the treatment of cancer.

Ostrow S, Van Echo D, Whitacre M, Aisner J, Simon R, Wiernik PH. Ostrow S, et al. Cancer Treat Rep. 1981 Mar-Apr;65(3-4):323-5. Cancer Treat Rep. 1981. PMID: 7237454

3

Cyclophosphamide and dimethylsulfoxide in the treatment of squamous carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics.

Fuks JZ, Egorin MJ, Aisner J, Ostrow SS, Klein ME, Bachur NR, Colvin M, Wiernik PH. Fuks JZ, et al. Among authors: ostrow ss. Cancer Chemother Pharmacol. 1981;6(2):117-20. doi: 10.1007/BF00262327. Cancer Chemother Pharmacol. 1981. PMID: 7307230

4

Randomized study of cyclophosphamide, doxorubicin, and etoposide (VP16-213) with or without cisplatinum in non-small cell lung cancer.

Fuks JZ, Aisner J, Van Echo DA, Schipper H, Levitt M, Ostrow S, Wiernik PH. Fuks JZ, et al. Among authors: ostrow s. J Clin Oncol. 1983 May;1(5):295-301. doi: 10.1200/JCO.1983.1.5.295. J Clin Oncol. 1983. PMID: 6686849 Clinical Trial.

5

High-dose cis-diamminedichloro-platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy.

Ostrow S, Egorin M, Aisner J, Bachur N, Wiernik PH. Ostrow S, et al. Cancer Clin Trials. 1980 Spring;3(1):23-7. Cancer Clin Trials. 1980. PMID: 7190082

6

Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms.

Ostrow S, Egorin MJ, Hahn D, Markus S, Leroy A, Chang P, Klein M, Bachur NR, Wiernik PH. Ostrow S, et al. Cancer. 1980 Oct 15;46(8):1715-21. doi: 10.1002/1097-0142(19801015)46:8<1715::aid-cncr2820460802>3.0.co;2-h. Cancer. 1980. PMID: 7191768

7

Nodular lymphoma. Prolongation of survival by complete remission.

Diggs CH, Wiernik PH, Ostrow SS. Diggs CH, et al. Among authors: ostrow ss. Cancer Clin Trials. 1981;4(2):107-14. Cancer Clin Trials. 1981. PMID: 7249248

8

Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma.

Fuks JZ, Egorin MJ, Aisner J, Van Echo DA, Ostrow S, Bachur NR, Wiernik PH. Fuks JZ, et al. Among authors: ostrow s. Cancer Chemother Pharmacol. 1983;10(2):104-8. doi: 10.1007/BF00446219. Cancer Chemother Pharmacol. 1983. PMID: 6299598

9

Causes of death in patients with non-Hodgkin's lymphoma.

Ostrow S, Diggs CH, Sutherland J, Wiernik PH. Ostrow S, et al. Cancer. 1981 Aug 1;48(3):779-82. doi: 10.1002/1097-0142(19810801)48:3<779::aid-cncr2820480320>3.0.co;2-3. Cancer. 1981. PMID: 7248904

10

Nodular poorly differentiated lymphocytic lymphoma: changes in histology and survival.

Ostrow SS, Diggs CH, Sutherland JC, Gustafson J, Wiernik PH. Ostrow SS, et al. Cancer Treat Rep. 1981 Nov-Dec;65(11-12):929-33. Cancer Treat Rep. 1981. PMID: 7028254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters